Director George Tidmarsh resigns from Revelation Biosciences board to avoid conflict of interest

REVELATION BIOSCIENCES, INC.

George Tidmarsh, MD, PhD resigned from the Board on May 23, 2025, to avoid conflict with new US governmental agency work.
Board size reduced from 5 to 4; Lakhmir Chawla, MD reclassified as Class C Director.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
Tidmarsh served as a Class C Director for 5 years; term was set to expire at the 2025 Annual Meeting.

item 5.02item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

George Tidmarsh

Director

REVB · REVELATION BIOSCIENCES, INC.

Effective: 2025-05-23
Filed: May 28, 2025 23:59 UTC

On May 23, 2025, George Tidmarsh, M.D., Ph.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the “Company”).

Source: SEC EDGAR

accession 0000950170-25-078340

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.